Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron

• Published in: Scientific reports Vol. 13; no. 1; pp. 17404 - 11
• Main Authors: Amano, Masayuki, Otsu, Sachiko, Uemura, Yukari, Ichikawa, Yasuko, Matsumoto, Shota, Higashi-Kuwata, Nobuyo, Matsushita, Shuzo, Shimada, Shinya, Mitsuya, Hiroaki
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 13.10.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/250/255; 631/250/590; 692/699/255; Humanities and Social Sciences; Immunoglobulin G; multidisciplinary; Neutralization; Risk factors; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Vaccines

SARS-CoV-2-BA.4/5-adapted-bivalent-BNT162b2-vaccine ( bv BNT), developed in response to the recent emergence of immune-evasive Omicron-variants, has been given to individuals who completed at least 2-doses of the monovalent-BNT162b2-vaccine ( mv BNT). In the present cohort study, we evaluated neutra...